INDP Indaptus Therapeutics Inc

Top Stocks to watch tomorrow 1 / 2 $INDP $FTFT $VEEA $PDSB $VNCE VEEA: Getting up on 4hours charts. Key support zone at 3.1 - 3.35. Next key level to test 4.65 - 4.9. Currently at 4.18 FTFT: After a nice run FTFT fell to its key support zone of 4.9 - 5.4. It may bounce off this support zone to test 6.65 - 7.15 zone again. Currently at 5.4 INDP: Initially alerted at 1.76. Currently at 3.15. Looking good on daily. chart with updated key support zone at 2.2 - 2.4. Next key level to test 3.55 - 3.75. PDSB: Getting up on 4hours chart with key support zone at 0.31 - 0.34. Next key level to test 0.48 - 0.52. Current overnight price is 0.39 VNCE: Good close of daily candle. Key support at 5.8 - 6.20. Next key level to test 7.85 - 8.30. Currently at 7.22

$INDP where’s all the people posting saying “Our team got in at 1:25 and out at 2:50” come on you’re slacking 🤣

$INDP $1.18 Oferring folks !! Be very careful this run will end badly!! Based on the overall transaction parameters of 20,338,974 common shares for ~$24.0 million in gross proceeds, the effective purchase price averages approximately ~$1.18 per share.

$INDP is the company good? No. Is it now chinese and being ran up to sell their shares? Yes

$INDP — INDP continues to be one of the wildest smaller healthcare names after gaining roughly 249% during September. The company raised around $24M and is exploring early research around a sleep-related device following the Decoy20 reset. That makes this less about the old pipeline and more about what management decides to do with its newly raised capital. Definitely a speculative one, but the strategic pivot has kept retail attention elevated

$INDP — INDP has basically become a corporate-reset story. After discontinuing Decoy20 enrollment, the company raised roughly $24M and began exploring a new sleep/neurotechnology direction. With fresh capital and a completely different potential strategy, the important question now is what management actually decides to build or acquire. 👀

$INDP — September has been wild for Indaptus. The company raised roughly $24M and is exploring a new direction involving neurotechnology for sleep-related conditions after stopping enrollment in its Decoy20 cancer program. Definitely a major strategy shift, and now the question is how management puts that new capital to work.

$INDP the rise is too steady cup formation? secondary rise shows confidence. Cap approaching 500m shows confidence

$INDP Price 3.15 My post was "Initially alerted at 1.76. Looking good on daily. chart with updated key support zone at 2.2 - 2.4. Next key level to test 3.55 - 3.75." It hit our desired zone, went till 3.76 a while ago

$INDP Unbelievable that this company that has no revenue and nothing in the pipeline is still up at this price and actually went higher today....

$INDP I like how David Lazar essentially converted this ticker from israeli to chinese. And now they have their algo running up this scam lol. INDP used to never be able to hold any gains. Funny how now it holds highs nearly everyday. Issued out even more shares and they need to file another resale so until then, i'll enjoy more green.

$INDP I always look at is as a sign were going to have a busy day with INDP when it's active in pre-market, that doesn't mean it's going to go up as i've seen it active in PM and it tanks but never the less were going to have something to talk about lol

$INDP ticking time bomb. no active trials and a last minute pivot into some random clinical sector on sleep? ok, lol. they have all this raised money now and we're just waiting for these new shares to be unrestricted and hit the float. Another bio scam with some questionable direction. on watch for those share to become effective.

$INDP Those that ran this up knew that the private offering was coming. You are now the liquidity if you bought yesterday. Dilution is dilution whether it is private or public....

$INDP closed a $24M private placement stock purchase agreement, extending its funding deadline to Oct 16.

$INDP The closing date of the private placement from earlier in Sept has been extended to Oct 16. https://www.sec.gov/ix?doc=/Archives/edgar/data/1857044/000149315226045040/form8-k.htm Details of the private placement 👇

$INDP i give up, have no idea why it's doing this, but just as likely to go down same amount tomorrow

$INDP E*Trade has tons of shares available to short. This stock is done and it’s a bull trap!

$INDP I was hoping this would come back up again as the volume increased, but unfortunately, there is no volume to warrant a rise.

$INDP time to short. Classic reverse merger shell BS. Half a billion dollar market cap for a non-revenue company. insiders are con artist from china. David Lazar is a con himself.